Chinese Journal of Integrative Medicine

, Volume 17, Issue 1, pp 52–63 | Cite as

Clinical practice guideline of traditional medicine for primary osteoporosis

  • Yan-ming Xie (谢雁鸣)
  • Ya Yuwen (宇文亚)
  • Fu-hui Dong (董福慧)
  • Shu-chun Sun (孙树椿)
  • He-ming Wang (王和鸣)
  • Qing-si Liu (刘庆思)
  • Zhong-jian Hua (华中健)
  • Liang-xiao Ma (马良宵)
  • Xing Liao (廖 星)
  • Gui-qin Xu (徐桂琴)
  • Ying-jie Zhi (支英杰)
  • Lu-fang Niu (牛潞芳)
  • Chang-sheng Wu (武常生)
Regulation and Guideline


Bone Mineral Density Osteoporosis Postmenopausal Osteoporosis Primary Osteoporosis Promote Blood Circulation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    The fourth international session on Osteoporosis. Hong Kong (Chin)1993.Google Scholar
  2. 2.
    Li ZL. Diagnosis and treatment on primary osteoporosis. Chin J Pain Med (Chin) 2006;12(1):40–43.Google Scholar
  3. 3.
    Liu ZH. Bone mineral and clinical. Beijing: Chinese Science and Technology Publishing House; 2006:2–37,957–958.Google Scholar
  4. 4.
    Scottish Intercollegiate Guidelines Network (SIGN). Management of osteoporosis. A national clinical guideline. Edinburgh (Scotland): Scottish Intercollegiate Guidelines Network (SIGN) 2003;Jun:1–45.Google Scholar
  5. 5.
    Qing L, Zheng ZY. A period of ten years between 2000 and 2010 for osteoarthropathy. Chin J Osteoporos (Chin) 2000;6(4):90–91.Google Scholar
  6. 6.
    Kanis JA, Melton LJ 3rd, Christiansen Claus, Johnston CC, Khaltaev. The diagnosis of osteoporosis. J Bone Miner Res 1994;9:1137–1141.CrossRefPubMedGoogle Scholar
  7. 7.
    Chinese Society of Osteoporosis and Bone Mineral Disease Branch, Chinese Medical Association. Diagnosis and treatment guideline on primary osteoporosis (discussion paper). Chin J Gen Pract (Chin) 2006;5:455–457.Google Scholar
  8. 8.
    Xie YM, Zhu YY, Ge JR, Piao HY, Yu J, Wang HM, et al. Study on the TCM general syndrome of osteoporosis based on the clinical epidemiological investigation. World Sci Technology-modernization Tradit Chin Med Mater Med (Chin) 2007;9(2):38–44.Google Scholar
  9. 9.
    Fang CH, Geng JJ, Zhang YZ, Xia DS, Yin T, Liu JX, et al. Study on distribution and grouping regularity of TCM syndrome in 1000 cases of senile osteoporosis. Chin J Inform Tradit Chin Med (Chin) 2007;14(5):15–17.Google Scholar
  10. 10.
    Hodgson SF, Watts NB, Bilezikian JP, Clarke BL, Gray TK, Harris DW, et al. American association of clinical endocrinologists medical guidelines for clinical practice for the prevention and treatment of postmenopausal osteoporosis. Endocr Pract 2003;9:544–564.PubMedGoogle Scholar
  11. 11.
    Carey RP, Plehwe WE. Preventing osteoporosis: outcomes of the Australian fracture prevention summit. MJA 2002;176(Suppl):1–16.Google Scholar
  12. 12.
    Singapore Ministry of Health. Osteoporosis. Singapore: Singapore Ministry of Health; 2002 Feb. 63 p.Google Scholar
  13. 13.
    North American Menopause Society. Management of osteoporosis in postmenopausal women: 2006 position statement of the north American menopause society. Menopause 2006;13:340–367.CrossRefGoogle Scholar
  14. 14.
    Institute for clinical systems improvement (ICSI). Diagnosis and treatment of osteoporosis. Bloomington (MN) 2006;Jul:1–65.Google Scholar
  15. 15.
    Cao YF, Liu QS, Liu HM. Discussion on TCM syndrome and treatment principle of osteoporosis. Chin J Osteop (Chin) 2002;8367–369.Google Scholar
  16. 16.
    Chen L, Zhu CY, Wang XP, Xu M. Meta analysis on the effects of Chinese herb for invigorating kidney on bone density in women with postmenopausal osteoporosis. Chin J Clin Rehal (Chin) 2004;8:6703–6705.Google Scholar
  17. 17.
    Chen YP, Liu XQ. Health education progress on primary osteoporosis prevention. Chin J Nurs (Chin) 2004;39:440–442.Google Scholar
  18. 18.
    Snelling AM, Crespo CJ, Schaeffer M, Smith S, Walbourn L. Modifiable and nonmodifiable factors associated with osteoporosis in postmenopausal women: results from the Third national health and nutrition and examination survey, 1988–1994. J Womens Health Gend Based Med 2001;10: 57–65.CrossRefPubMedGoogle Scholar
  19. 19.
    Lowe NM, Fraser WD, Jackson MJ. Is there a potential therapeutic value of copper and zinc for osteoporosis? Proc Nutr Soc 2002;61:181–185.CrossRefPubMedGoogle Scholar
  20. 20.
    Xichiliangji. Survey on diagnosis and treatment of osteoporosis. Osteoporosis Japan 2002;10:196.Google Scholar
  21. 21.
    Chaputy MC, Arlot ME, Delmas PD, Meunier PJ. Effect of calcium and cholecalciferol treatment for three years on hip fractures in elderly women. BMJ 1994;308:1081–1082.Google Scholar
  22. 22.
    Bonjour JP, Sclurch MA, Chevalley T, Ammann P, Rizzoli Rl. Protein intake, IGF-1 and osteoporosis. Osteoporos Int 1997;7(suppl 3):36–42.CrossRefGoogle Scholar
  23. 23.
    SUN Si-miao. JIAO Zhen-lian, SU Li, LI Jing-rong revision. SUN Zhen-ren qian jin fang. Beijing: The people’s Medical Publishing House;1996:322.Google Scholar
  24. 24.
    Zhou WQ, Sha FT, Gao P, Li BH. Dialectical therapeutics of Chinese medical food. Beijing: People’s Medical Publishing House (Chin) 2002;418–420.Google Scholar
  25. 25.
    Yu DH, Wang JH. Effect on change of T lymphocyte in peripheral blood of middle aged and aged people before and after treatment with fi tness qigong and wu-qin-xi for 6 month. Chin J Sports Med (Chin) 2007;26:206–207.Google Scholar
  26. 26.
    Maciaszek J, Osiński W, Szeklicki R, Stemplewski R. Effect of Tai Chi on body balance: randomized controlled trials in men with osteopenia or osteoporosis. Am J Chin Med 2007;35:1–9.CrossRefPubMedGoogle Scholar
  27. 27.
    Zeng YG, Zhou XQ, Wang AL, Yang BL, Wang ST. Research on impact of fitness Gigong and baduan jin on fi gure and physical function among middle aged and aged people. Beijing Sports Univ (Chin) 2005;28:1207–1209.Google Scholar
  28. 28.
    Shang TG. Interpretation on health preserving in internal classic of Inner Canon of Yellow Emperor. Chin Arch Tradit Chin Med (Chin) 2004;22:2310–2311.Google Scholar
  29. 29.
    Xie YM, Zhu YY, Wu TX. Effects and safety of traditional Chinese medicine for treating menopause osteoporosis: a systematic review. Chin J Evidence-Based Med (Chin) 2005;5:29–41, 74.Google Scholar
  30. 30.
    Gu GS, Li ZC, Wu ZY. Meta analysis on the prevention and treatment of osteoporosis with Gushukang granules. Chin J Clin Rehab (Chin) 2005;9(35):124–126.Google Scholar
  31. 31.
    Zhang J, Wu LS, Sun SC, Shi GT, Wang HM, Shen L, et al. Clinical study on effect of Jintiange Capsules for treatment of primary osteoporosis in 660 cases. Chin J Osteop (Chin) 2005;11:490–495.Google Scholar
  32. 32.
    Shang YM, Liu YY Li HP. Clinical study on effect of Weilinxian Capsule for treatment of menopause osteoporosis. Chin J Tradit Chin Med West Med Crit Car (Chin) 2007;14:55.Google Scholar
  33. 33.
    Dong YF. Clinical study on effect of herbs including herba epimedii for treatment of osteoporosis. J Chin Med Mater (Chin) 2004;27:620–622.Google Scholar
  34. 34.
    Zhao LN. Clinical preventional and curative effect evaluation of herba epimedii on osteoporosis. Mod J Integr Tradit Chin West Med (Chin) 2003;12:922–923.Google Scholar
  35. 35.
    Zeng YH. Post-menopause osteoporosis treated with herba epimedii: a report of 50 cases. Shaanxi J Tradit Chin Med (Chin) 2005;26:405–406.Google Scholar
  36. 36.
    Xie YM, Wang HM, Shen L, Cui TH, Ge JR, Kou QA, et al. Clinical study on effect of Qianggu Capsule on primary osteoporosis (decrease in bone content). Chin J Inform Tradit Chin Med (Chin) 2004;11:482–486.Google Scholar
  37. 37.
    Wang HM, Tian JZ, Peng SL, Shen L, Wu YN, Lin BH, et al. Clinical observation on treatment for osteopenia at the earlier period of osteoporosis with strong bone capsule. China J Orthop Trauma (Chin) 2003;16:692–694.Google Scholar
  38. 38.
    Tang JT, Morton SC, Rubenstein LZ, Mojica WA, Maglione M, Suttorp MJ, et al. Interventions for the prevention of falls in older adults: systematic review and meta-analysis of randomised clinical trials. BMJ 2004;328:653–654.CrossRefGoogle Scholar
  39. 39.
    Roberson MC, Campbell AJ, Gardner MM, Devlin N. Preventing injuries in older people by preventing falls: a meta-analysis of individual-level data. J Am Geriatr Soc 2002;50:905–911.CrossRefGoogle Scholar
  40. 40.
    Thorsten N, Matthias B. Preventing falls in communitydwelling frail older people using a home intervention team (HIT): results from the randomized Falls-HIT trial. J Am Geriatr Soc 2003;51:300–305.CrossRefGoogle Scholar
  41. 41.
    Bischoff-Ferrari HA, Dawson-Hughes B, Willett WC, Staehelin HB, Bazemore MG, Zee RY, et al. Effect of Vitamin D on falls: a meta-analysis. JAMA 2004;291:1999–2006.CrossRefPubMedGoogle Scholar
  42. 42.
    Liu ZH. Bone mineral and clinical. Beijing: Chinese Science and Technology Publishing House; 2006:2–37,957–958.Google Scholar
  43. 43.
    Deng WM, Cui WL, Shen YG, Yang QH, He YS, Wei S. Effect of 2-year treatment with Bushen Zhuanggu Granules for postmenopausal osteoporosis. J Guangzhou Univ Tradit Chin Med (Chin) 2002;19:275–278.Google Scholar
  44. 44.
    Deng WM, Cui WL, He YS, Wei S. Effect of Bushen Zhuanggu Granules on bone content and bone mineral density in male patient with osteoporosis: five-year observation. Chin J Clin Rehabi (Chin) 2005;9:150–151.Google Scholar
  45. 45.
    Deng WM, Yang QH, Shen YG, Cui WL, He YS, Wei S. Five-year observation on effect of Bushen Zhuanggu Granules on postmenopausal osteoporosis women. Chin J Clin Rehab (Chin) 2003;7:2964–2965.Google Scholar
  46. 46.
    Wang XK, Wang Y, Yang YG. Clinical observation on effect of Weilinxian Capsule on postmenopausal osteoporosis. Chin J Mater Child Health Care (Chin) 2009;24:1707–1708.Google Scholar
  47. 47.
    Wu XF. Clinical study on effect of Weilinxian Capsule on bone mineral density with primary osteoporosis. Med Industry Inform (Chin) 2006;3:52–54.Google Scholar
  48. 48.
    Mao YJ, Wu LG, Liu K, Xu JC, Shi XL. The report of Weilinxian Capsule on improvement bone mineral density in 102 cases with osteoporosis. Chin J Mod Appl Pharm (Chin) 2006;23:416–418.Google Scholar
  49. 49.
    Wang HM, Ge JR, Tian JZ, Peng SL, Shen L, Wu YN. Clinical study on effect of Qianggu Capsule (osteopractic total plavone) on bone pain in osteoporosis. Chin J Tradit Med Traum orthop (Chin) 2005;13(6):38–42.Google Scholar
  50. 50.
    Xie YM, Cui TH, Gao R, Du BJ, zhang WJ, Ma HB, et al. Clinical study of Qianggu Capsule in treating primary osteoporosis with Kidney-yang defi ciency syndrome. Tradit Chin Drug Res Clin Pharm (Chin) 2000;11:197–201.Google Scholar
  51. 51.
    Wang HM, Ge JR, Tian JZ, Peng SL, Shen L, Wu YN. Clinical study of Qianggu Capsule in treating primary osteoporosis. Tradit Chin Drug Res Clin Pharm (Chin) 2004;15:284–287.Google Scholar
  52. 52.
    Li JH, Zhao GL. Clinical study on effect of Qianggu Capsule on postmenopausal osteoporosis. Pract Clin J Integr Tradit Chin West Med (Chin) 2008;8:19–20.Google Scholar
  53. 53.
    Cao LS. Observation of curative effect of modifi ed Liuwei Dihuang Pill on postmenopausal osteoporosis. J Henan Univ Chin Med (Chin) 2004;19(4):42.Google Scholar
  54. 54.
    Zhang J, Yin SL, Yin HQ, Ling HW, Li W, Li XQ. Observation on effect of Liuwei Dihuang Decoction on postmenopausal osteoporosis. J Clin Intern Med (Chin) 2003;20:10.Google Scholar
  55. 55.
    Zou CQ. Observation on effect of modifi ed Liuwei Dihuang Decoction on postmenopausal osteoporosis. Chin J Inform Tradit Chin Med (Chin) 2005;12(8):75, 88.Google Scholar
  56. 56.
    Shi Y, Shi GT, Shi YY. A clinical study on prescription osteoporosis with Gubenzhuangu Capsule. Chin J Tradit Med Traum Orthop (Chin) 2005;13:11–15.Google Scholar
  57. 57.
    Gao Y, Wu Z, Wu LY. Clinical observation on effect of Jintiange Capsule on osteoporosis. Hubei J Tradit Chin Med (Chin) 2006;28:43.Google Scholar
  58. 58.
    Han YW, Wu CE. Clinical study of traditional Chinese medicine on osteoporosis. J Shanxi Coll Tradit Chin Med (Chin) 2006;17(6):24–25.Google Scholar
  59. 59.
    Lan ZX, Li LZ, Zhang JT, Wang ZQ, Chen C, Liu JY. Clinical study of Guli Granule on treating primary osteoporosis deficiency in spleen and kidney. Sichuan J Tradit Chin Med (Chin) 2006;24:75–77.Google Scholar
  60. 60.
    Wang HM, Ge JR, Shi GT, Zhao WH, Tian W. Clinical study on the effect of Gushukang Capsule in primary osteoporosis treatment. Chine J Tradit Med Traum Orthop (Chin) 2006;14:10–15.Google Scholar
  61. 61.
    Lu ZD, Wang YS. Observation on clinical effect of Gushukang Capsule on primary osteoporosis with moderate-severe grade. Chin J Clin Rehabi (Chin) 2004;8:3652.Google Scholar
  62. 62.
    Ma Q, Liu RR, Yang YZ. Study on effect of Gushukang Capsule on postmenopausal osteoporosis with 86 cases. Shaanxi J Tradit Chin Med (Chin) 2004;25:1096–1097.Google Scholar
  63. 63.
    Liu ZW, Gang Pi, You T, Jiang SH. Observation on longterm therapeutic effects of Gushukang Granules on primary osteoporosis. Chin Arch Tradit Chin Med (Chin) 2001;19:475–476, 519.Google Scholar
  64. 64.
    Chen ZX, Xu XJ, Huang G. Clinical study of the combined therapy with gushukang and calcium for the treatment of postmenopausal osteoporosis. Chin J Bone Tumor and Bone Dis (Chin) 2004;3:18–20.Google Scholar
  65. 65.
    Jiang SY, Shang YP, Wu LS, Liu BY, Zhang L, Guo RY. Clinical observation on effect of Gushukang Granules in osteoporosis treatment: a repot of 300 cases. Chin J Osteop (Chin) 1995;1(2):167–169, 158.Google Scholar
  66. 66.
    Chinese Pharmacopeia Commission. Pharmacopoeia of People’s Republic of China. Beijing: Chinese Medical Press 2010:597–799.Google Scholar
  67. 67.
    Wang CH, Tian LM, Feng W, Cheng XJ, Yao JF, Wang W, et al. Influence of acupuncture on bone density and hemorheology of postmenopausal osteoporosis. J Emerg Syndroms Tradit Chin Med (Chin) 2004;13:284–285.Google Scholar
  68. 68.
    Zhou XL, Bao SY. Influence of acupuncture with shuangguyitong on bone density of postmenopausal osteoporosis. Hubei J Tradit Chin Med (Chin) 2005;27(6):49–50.Google Scholar
  69. 69.
    Wang DY, Cai H, Zhuo TJ. Influence of acupuncturing the back-point on lumbar vertebrae bony density of osteoporosis. Hubei J Tradit Chin Med (Chin) 2001;23(2):6.Google Scholar
  70. 70.
    Chen L, Zhu CY, Wang XP, Xu M. Meta analysis on the effect of Chinese herbs for invigorating kidney on bone mineral density in women with postmenopausal osteoporosis. Chin J Clin Rehab (Chin) 2004;8:6703–6705.Google Scholar
  71. 71.
    Yi CS, Liu XQ. Clinical observation on effect of invigorating kidney herbs on primary osteoporosis. J Hunan Coll Tradit Chin Med (Chin) 2003;23:36–37.Google Scholar
  72. 72.
    Wang CH, Zhang ZH, Ma J, He YN, Wang ZO. Clinical study on effect of invigorating kidney on osteoporosis. Acta Chin Med Pharm (Chin) 1998;5:20–21.Google Scholar
  73. 73.
    Mu RH, Quan XB, Zhang CW. Curative effect observation on traditional Chinese medicine warmed kidney and benefited spleen combined with massage method in treating old osteoporosis. Zhejiang J Integr Tradit Chin West Med (Chin) 2005;15:535–537.Google Scholar
  74. 74.
    Tang QW. Clinical study on prescription forty-seven senile osteoporosis with invigorating kidney and benefi ted spleen. Hubei J Tradit Chin Med (Chin) 2000;22:25.Google Scholar
  75. 75.
    Zhou YL. Clinical study on prescription fifty-eight senile osteoporosis with invigorating kidney and benefi ted spleen. Chin J Rehabil Theory Pract (Chin) 2003;9:382.Google Scholar
  76. 76.
    Ma WX, Li CP. Report on the effect of invigorating kidney and benefited spleen in postmenopausal osteoporosis treatment with 30 cases. J Tradit Chin Orthop Traumatol (Chin) 2003;15:32.Google Scholar
  77. 77.
    Song XW, Shen PZ, Chen BX. Clinical studies of traditional Chinese herb medicine on post-menopausal osteoporosis. China J Orthop Trauma (Chin) 2001;14:476.Google Scholar
  78. 78.
    Ma RL, Wu YC, Xu XM. Effect of Tuina treatment on BMD in women with postmenopausal osteoporosis. Pract Geriatr (Chin) 2004;20:11–12.Google Scholar
  79. 79.
    Watts NB, Harris ST, Genant HK. Treatment of painful osteoporotic vertebral fractures with percutaneous vertebroplasty or kyphoplasty. OsteoporosInt 2001;12:429–437.CrossRefGoogle Scholar
  80. 80.
    Barr JD, Barr MS, Lemley TJ, McCann RM. Percutaneous vertebroplasty for pain relief and spinal stabilization. Spine 2000;25:923–928.CrossRefPubMedGoogle Scholar
  81. 81.
    Garfin S, Lin G, Lieberman I. Retrospective analysis of the outcomes of balloon kyphoplasty to treat vertebralbody compression fracture(VCF)refractory to medical management. Eur Spine J 2001;10(Suppl1):S7.Google Scholar
  82. 82.
    Huang RJ, Wei J, Huang MA, An LS, Cai Q. WHOQOL-100 questionnaire for assessment of life quality of patients with osteoporosis and effect of nursing intervention. Chin General Pract (Chin) 2006;9:1798–1800.Google Scholar
  83. 83.
    Pan X. Study on rehabilitation guidance and nursing of point injection on primary osteoporosis. Family Nurse (Chin) 2007;5:32–33.Google Scholar
  84. 84.
    Miller PD, Bonnick SL. Clinical application of bone densitometry. in primer on the metabolic bone disease and disorder of mineral metabolism.edited by favus M. Philadelphia: Lippincott Williams and Wikins;1999:152–159.Google Scholar
  85. 85.
    Bonnick SL. Bone Densitometry in clinical medicine. Chapter 9: Clinical indications for bone densitometry, Totowa NJ: Human Press;1998:197–210.Google Scholar
  86. 86.
    Duan HG, Ni JX. Qualitative and quantitative measurements on pain. Med J Liaoning (Chin) 1996;10:1–2.Google Scholar
  87. 87.
    Genant HK, Engelke K, Fuerst T, Glüer CC, Grampp S, Harris ST. Noninvasive assessment of bone mineral and structure:state of the art. J Bone Miner Res 1996;11:703–730.Google Scholar
  88. 88.
    Ware JE JR, Gandek B. Overview of the SF-36 health survey and the international quality of life assessment (IQOLA) project. J Clin Epidemiol 1998;51:903.CrossRefPubMedGoogle Scholar
  89. 89.
    Liu JP. The composition of evidence body of traditional medicine and recommendations for its evidence grading. Chin J Integr Tradit West Med (Chin) 2007;27:1061–1062.Google Scholar
  90. 90.
    GRADE Working Group. Grading quality of evidence and strength of recommendations. BMJ 2004;328:1490–1497.CrossRefGoogle Scholar

Copyright information

© Chinese Association of the Integration of Traditional and Western Medicine and Springer-Verlag Berlin Heidelberg 2011

Authors and Affiliations

  • Yan-ming Xie (谢雁鸣)
    • 1
  • Ya Yuwen (宇文亚)
    • 1
  • Fu-hui Dong (董福慧)
    • 2
  • Shu-chun Sun (孙树椿)
    • 2
  • He-ming Wang (王和鸣)
    • 3
  • Qing-si Liu (刘庆思)
    • 4
  • Zhong-jian Hua (华中健)
    • 5
  • Liang-xiao Ma (马良宵)
    • 6
  • Xing Liao (廖 星)
    • 1
  • Gui-qin Xu (徐桂琴)
    • 1
  • Ying-jie Zhi (支英杰)
    • 1
  • Lu-fang Niu (牛潞芳)
    • 1
  • Chang-sheng Wu (武常生)
  1. 1.Institute of Basic Research in Clinical MedicineChina Academy of Chinese Medical SciencesBeijingChina
  2. 2.Wangjing Hospital of China Academy of Chinese Medical ScienceBeijingChina
  3. 3.Fujian University of Chinese MedicineFuzhouChina
  4. 4.Orthopedic Hospital of Guangzhou University of Traditional Chinese MedicineGuangzhouChina
  5. 5.China Traditional Chinese Medicine Publishing HouseBeijingChina
  6. 6.Beijing University of Chinese MedicineBeijingChina

Personalised recommendations